This is a prospective study to compare the safety and efficacy of treating small aneurysms.
RIA has a rich history of participation in clinical research and innovation dating back to the 1980s. Many of our physicians believe it is important to contribute to science and advance medicine. Further, our patients can benefit from access to emerging and novel technology.
In recent years, RIA Research has focused on building infrastructure and has experienced significant growth. Today, the department employs seven staff, including five masters-prepared staff (two of whom are Registered Nurses).
The full spectrum of clinical research activities is provided by department staff, including evaluation of potential research opportunities, preparation and submission of all regulatory documentation, negotiation and management of contracts and budgets, administrative oversight, site implementation, invoicing, sponsor communications, interactions with auditors and inspectors, data collection and management, training, and maintenance of all records. In addition to radiology studies in the outpatient setting, the RIA Research Department has experience with clinical studies that have an inpatient component, including neurointerventional, peripheral interventional, body interventional, and interventional oncologic procedures.
At present, RIA radiologists are the principal investigators for approximately twenty studies that are actively enrolling, in data collection or in the follow-up phase. We are in early discussions with sponsors for many new studies. Previous research activities include an additional 40+ studies that have been completed.
You Might Also Enjoy...
This is a prospective study to compare the safety and efficacy of treating small aneurysms.
Safety and Effectiveness of the Treatment of Wide-Neck, Intracranial, Saccular Aneurysms with the Next Generation Neuroform Stent System.
Intravenous (IV) tissue plasminogen activator (tPA) administration has been shown to be safe and effective for treatment of Acute Ischemic Stroke (AIS) within 3 hours of symptom onset, and newer evidence has shown potential benefit out to 4.5 hours.
StrokeNet, developed by NIH, is the new structure for federal funding of all aspects of stroke research including prevention, acute treatment, and recovery / rehabilitation.
The full name of this study is: Barrel™: Study of the Reverse Medical Barrel™ Vascular Reconstruction Device for Adjunctive Treatment to Embolic Coils for Wide-Neck, Intracranial, Bifurcating/Branching Aneurysms.
This is a prospective, multi-center study of patients treated in accordance with the cleared indications for the Penumbra SMART CoilTM System (SMART), Penumbra Coil 400TM (PC 400), and Penumbra Occlusion DeviceTM (POD).